Ediang Duo Tablet 5/850 mg
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
IlYang Pharmaceutical Co., Ltd.
MFDS item code 202201336 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes
This medication is used as an adjunct to dietary and exercise measures to improve glycemic control in adults with type 2 diabetes. It should be used cautiously in adult diabetic patients who have cardiovascular disease and are not achieving adequate blood glucose control, and it is important to consult expert guidelines regarding the cardiovascular effects of the drug. Therefore, this medication is used to assist in blood sugar control and support safer diabetes treatment.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. No dose adjustment is required for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily, so treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Do not administer to the following patients, item 2)). In patients aged 75 years or older, consider renal function and the risk of volume depletion.
This medication is used for the treatment of diabetes and helps in blood sugar control. Care is needed when taking this medication as a rare side effect of severe lactic acidosis may occur. Lactic acidosis can be a dangerous condition caused by the excessive accumulation of lactic acid in the body. When used in combination with other diabetic medications, hypoglycemia may occur, so it is important to be aware of symptoms of low blood sugar. Patients with moderate to severe renal impairment or specific health conditions such as acute renal problems, severe infections, or heart failure should not take this medication. Furthermore, if undergoing tests or surgeries involving iodinated contrast agents, this medication should be discontinued for a certain period, and it should only be resumed after confirming normal kidney function. Women who are pregnant or breastfeeding should not take this medication, and it is not recommended for children or adolescents under 18 years of age. This medication can lead to fluid loss, so patients with dehydration or cardiovascular disease should be cautious when taking it. During treatment, side effects such as symptoms of hypoglycemia, urinary infections, genital infections, and increased urination may occur, so immediate consultation with medical personnel is advised if symptoms arise. Vitamin B12 deficiency may occur, so for long-term use, regular blood tests to check vitamin B12 levels are advisable. Alcohol consumption may increase the risk of lactic acidosis, so it is recommended to avoid drinking while taking this medication. If sudden severe dehydration, infections, surgeries, or heart problems occur during the use of this medication, it should be immediately discontinued, and medical personnel should be notified. Moreover, when taking this medication in conjunction with insulin or sulfonylureas, the risk of hypoglycemia may necessitate dosage adjustments of the medications. Elderly patients may face increased risks of renal function decline, thus regular kidney function tests are necessary and it is advisable not to use the maximum dosage. In the case of overdose, serious side effects such as lactic acidosis may occur, so it should be taken precisely according to medical advice. Lastly, this medication should be kept out of reach of children and stored in its original packaging to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to maintain storage temperatures between 1 to 30 degrees Celsius (room temperature) to preserve the medication's effectiveness and prevent deterioration.
Biconvex oval film-coated tablet with a white color and a yellowish tint
10 tablets/box (10 tablets/PTP x 1), 60 tablets/box (10 tablets/PTP x 6), 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
IlYang Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.